The New Paper

February 5, 2021

Johnson and Johnson requests emergency approval for coronavirus vaccine

Johnson & Johnson requested emergency use authorization from the FDA for its single-dose coronavirus vaccine yesterday. The vaccine was found to be 66% effective overall in late-stage clinical trials (including 72% in the US and 57% in South Africa).
This story is from the February 5, 2021 edition of The New Paper – a clear, concise daily briefing that makes fact-first news easy to consume. Try it today.